Fmoc-L-proline

    • Product Name: Fmoc-L-proline
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 154015
    Product Name Fmoc-L-proline
    Synonym Fmoc-Pro-OH; N-α-Fmoc-L-proline
    Cas Number 71989-31-6
    Molecular Formula C20H19NO4
    Molecular Weight 337.37 g/mol
    Appearance White to off-white powder
    Purity ≥98% (HPLC)
    Melting Point 113-116 °C
    Optical Rotation [α]D20 = -30° (c=1, DMF)
    Storage Conditions Store at 2-8 °C, protected from light and moisture
    Solubility Soluble in DMF, DMSO, and methanol

    As an accredited Fmoc-L-proline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Fmoc-L-proline, 5 g, packaged in a glass vial with a secure cap, stored dry and protected from light.
    Container Loading (20′ FCL) Fmoc-L-proline is packed in sealed drums, palletized, securely stowed, and loaded into a 20-foot FCL container for safe transport.
    Shipping Fmoc-L-proline ships as a stable, off-white powder at ambient temperature in sealed, moisture-resistant packaging with desiccant. Store at 2–8°C, protected from light and moisture. Handle with standard PPE. Not classified as dangerous goods under normal shipping conditions; avoid contact with acids, bases, and strong oxidizers.
    Storage Store Fmoc-L-proline in a tightly sealed container, protected from light and moisture, in a cool, dry, well-ventilated area. For long-term storage, refrigeration at 2–8 °C or –20 °C is recommended. Keep away from strong oxidizing agents and incompatible materials. Ensure the container is resealed immediately after use to maintain stability.
    Shelf Life Store tightly sealed, protected from light and moisture at 2–8°C; shelf life approximately two to three years.
    Application of Fmoc-L-proline

    In automated solid-phase peptide synthesis, Fmoc-L-proline is supplied as a dry protected amino acid with molecular weight 337.37 g/mol and CAS 71989-31-6. The material is dissolved in DMF or NMP at 0.3–0.5 M and activated with Oxyma/DIC or HOBt/DIC at a molar excess of 4:4:4 relative to the deprotected amine on the resin. Because the proline nitrogen is secondary, acylation of a primary amine is slower than that observed with Fmoc-protected primary amino acids, so automated methods often specify double coupling at 45°C for 30 min per cycle on Wang, Rink amide AM, or 2-chlorotrityl supports with loading between 0.3 mmol/g and 0.8 mmol/g. Fmoc removal uses 20% piperidine in DMF in two cycles of 10 min each. UV monitoring at 304 nm quantifies the dibenzofulvene-piperidine adduct. The Kaiser ninhydrin test is not suitable for residual secondary amine control; the chloranil test or bromophenol blue test is applied instead. This process step is used in the assembly of proline-containing peptide APIs, including bivalirudin, linaclotide, desmopressin, and terlipressin, where proline residues define β-turn geometry or disulfide-constrained ring conformation.

    When Does Fmoc-L-proline at the C-Terminal Ester Position Accelerate Diketopiperazine Release?

    When Fmoc-L-proline is anchored through its carboxyl to 2-chlorotrityl chloride resin, cleavage of the Fmoc group with 20% piperidine exposes a secondary amine capable of intramolecular attack on the electron-deficient ester. After the next amino acid is coupled and its Fmoc group removed, the free N-terminal amine can attack the prolyl ester carbonyl. The resulting cyclo(dipeptide) is released from the resin. With proline at the C-terminal position, the constrained pyrrolidine ring reduces rotational freedom and increases the probability of cis-amide geometry that precedes diketopiperazine formation. The failure is commonly observed within a single 10 min piperidine deprotection cycle at 25°C on 2-chlorotrityl systems, producing premature peptide loss and low crude purity. The corrective process strategy is to load Fmoc-L-proline as a preformed Fmoc-Pro-AA-OH dipeptide, or to select a resin-linker system that does not leave a secondary amine in the critical C-terminal dipeptide stage. For marketed proline-containing peptide APIs, the C-terminal residue is usually not proline, so this failure mode is concentrated in research peptides, peptide libraries, and linker-fragment preparation rather than in large-scale API assembly.

    Fmoc-L-proline is converted into an immobilized secondary-amine organocatalyst by amide coupling to aminomethyl polystyrene with an amine loading of 1.0–1.2 mmol/g. The coupling uses HBTU and DIPEA in DMF. After Fmoc removal with 20% piperidine in DMF, the resin-bound proline is packed into a fixed-bed reactor for asymmetric aldol addition of acetone to 4-nitrobenzaldehyde. The feed consists of acetone and substrate in DMSO/acetone 4:1 v/v at 25°C, with a residence time of 30–60 min. Back-pressure and bed compression are the principal operational limits in continuous flow. Enantiomeric excess is monitored by chiral HPLC on a Chiralpak AD-H column with hexane/isopropanol 90:10 at 1.0 mL/min. Published data for the exact combination of aminomethyl polystyrene and Fmoc-L-proline in flow aldol systems is limited; results from homogeneous proline literature indicate enantiomeric excess from 60% to 90% for aromatic aldehydes under optimized water content, but transfer to the supported system requires individual validation. The downstream products are optically active β-hydroxy ketones used as intermediates in pharmaceutical route synthesis.

    Solution-Phase Coupling of Fmoc-L-proline to Glycine Benzyl Ester Yields Collagen-Mimetic Repeat Units With Controlled Optical Purity

    For collagen-mimetic peptides, Fmoc-L-proline is coupled to glycine benzyl ester in a mixed ethyl acetate/dichloromethane system using EDC/HOAt and N-methylmorpholine at 0–5°C. The resulting Fmoc-Pro-Gly-OBn is hydrogenolysed over 10% palladium on carbon in ethyl acetate to give Fmoc-Pro-Gly-OH. The dipeptide is then coupled repeatedly to generate (Pro-Hyp-Gly)ₙ or (Pro-Gly)ₙ repeat units used as triple-helical collagen mimetic probes. Solid-phase synthesis is preferred for longer sequences, but solution-phase fragment coupling is used when the target oligomer is shorter than 10–15 residues and requires single-lot optical purity. The product is isolated by precipitation from cold methyl tert-butyl ether and dried to a residual water content below 0.5% before chain assembly. These fragments are used in collagen-binding assays and in the preparation of protease-resistant collagen model substrates.

    When Fmoc-L-proline is Co-Assembled with Fmoc-Dipeptide Gelators for Three-Dimensional Cell Culture Substrates

    Fmoc-L-proline alone is not typically reported as an independent low-molecular-weight hydrogelator at neutral pH; published gelation data for the isolated compound are limited. The material is instead co-assembled with Fmoc-Phe or Fmoc-dipeptide gelators, where the pyrrolidine ring alters backbone torsion angles and modifies fibril stiffness without eliminating the aromatic π–π stacking required for self-supporting network formation. The resulting hydrogels are evaluated by oscillatory rheometry using plate-plate geometry at 25°C and 1% strain amplitude. Storage modulus values for Fmoc-peptide hydrogels of this class are commonly reported in the range of 1–10 kPa, but Fmoc-L-proline-specific co-gel data must be confirmed per batch because the proline residue can disrupt packing at higher molar fractions. These hydrogels are used as synthetic three-dimensional substrates for epithelial and mesenchymal cell culture in drug-screening formats.

    GMP Release Analytics and Chiral Purity Control for Fmoc-L-proline in Peptide API Manufacturing

    Before an Fmoc-L-proline lot enters the automated synthesis suite, the material is released against a defined specification that addresses identity, chemical purity, chiral purity, water content, and residual solvent. The table below summarises the release matrix.

    Test attributeMethodAcceptance criterion
    IdentityIR spectrophotometry against reference standardSpectrum matches reference lot
    Specific rotationPh. Eur. 2.2.7 polarimetry, c=1 in DMF[α]D20 −32° ± 2°
    Chemical purityHPLC-UV at 220 nm≥98.0% area
    Chiral purityChiral HPLC on polysaccharide stationary phaseFmoc-D-proline ≤0.5% area
    Water contentKarl Fischer coulometry≤0.5% w/w
    Residual DMFHeadspace GC-FID per Ph. Eur. 2.4.24≤880 ppm per ICH Q3C

    Chiral purity is process-defining because Fmoc-D-proline contamination at levels above the retention threshold changes the three-dimensional structure of the final peptide and is not corrected by subsequent coupling steps. The specific rotation of Fmoc-L-proline is measured at 20°C in DMF at a concentration of c=1; the accepted range is −32° ± 2°. Water content is controlled below 0.5% w/w because moisture competes with carboxyl activation during coupling. Residual DMF is limited to 880 ppm under ICH Q3C. These controls are implemented before the material enters the automated synthesis suite.

    Free Quote

    Competitive Fmoc-L-proline prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Fmoc-L-proline, systematically named (2S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylic acid, is a base-labile Nα-protected proline derivative used primarily as a building block in Fmoc solid-phase peptide synthesis. The compound is catalogued under CAS 71989-31-6, has the molecular formula C20H19NO4, and has a molecular weight of 337.37 g mol−1. Commercial lots are typically supplied as a white to off-white crystalline powder with an HPLC purity not less than 98.0%. Storage is assigned at 2–8 °C in a desiccated container. Supplier certificates of analysis normally report the D-enantiomer at ≤ 0.5%, a specific optical rotation near −31° to −33° when measured at 20 °C in DMF at c = 1.0 g/100 mL, and a loss on drying value of ≤ 0.5%. Because this is a reagent-grade chiral building block rather than a compendial drug substance, release limits vary by manufacturer and should be read against the lot-specific certificate. Commercial catalogue numbers are manufacturer-specific; the product is commonly listed under the abbreviation Fmoc-Pro-OH, but no harmonized model number exists across suppliers.

    The primary application is as a protected chiral building block for solid-phase synthesis of proline-containing peptides and peptidomimetics. It is also used in solution-phase fragment coupling where orthogonal Nα protection is required and where ultraviolet monitoring of protecting-group removal is advantageous.

    Why Does the Fmoc Group Dictate Coupling Sequence Design?

    The Fmoc group is removed by secondary amines such as piperidine through β-elimination of the fluorenylmethoxycarbonyl moiety, yielding dibenzofulvene and the unprotected amino group. This deprotection is orthogonal to the acid-labile side-chain protections used in Fmoc SPPS, including tert-butyl esters, trityl groups, and Pbf or Boc side-chain protections. Fmoc-L-proline therefore tolerates the acidic environment required for simultaneous side-chain deprotection and resin cleavage while remaining removable under mildly basic conditions at 20–25 °C. The molecule is freely soluble in DMF, NMP, and DMSO and poorly soluble in water, which restricts direct aqueous coupling protocols but is compatible with standard organic solvent-based automated synthesis.

    Because proline is a cyclic secondary amino acid, removal of the Fmoc group exposes a secondary amine that forms a tertiary amide when the next activated Fmoc-amino acid is coupled. This steric constraint reduces acylation rates relative to primary amine residues; coupling onto the proline nitrogen commonly requires a second coupling cycle or an extended reaction time. The constrained pyrrolidine ring imposes a restricted φ dihedral angle, which affects β-turn formation and cis/trans amide bond isomerization in the assembled sequence. In sequences where Fmoc-L-proline is coupled to a C-terminal amino acid on an acid-sensitive ester resin, premature Fmoc removal may allow diketopiperazine formation between the two residues, especially if the resin linker is labile and the C-terminal amino acid has a free carboxylate. To suppress this, the Fmoc group on proline is removed only immediately before the next coupling, and the deprotection time is kept at the lower end of the specified range.

    Coupling of Fmoc-L-proline itself is conducted with phosphonium or aminium reagents such as HATU in the presence of DIPEA, or with carbodiimide reagents such as DIC and the additive ethyl cyano(hydroxyimino)acetate. Preactivation in DMF or NMP at 0–5 °C for 3–5 min before addition to the resin minimizes premature decomposition of the active ester. On 2-chlorotrityl chloride resin, the first amino acid is often attached by dissolution in dichloromethane with DIPEA; Fmoc-L-proline is compatible with this approach. The residual solvent content of the attached resin should be confirmed by loss-on-drying or headspace gas chromatography when the peptide will be released under cGMP. Automated synthesizers typically use a solution concentration of 0.2–0.5 mol L−1 and a delivery path of fluoropolymer tubing; precipitation in the delivery line can occur if the solution is held at 4 °C without agitation.

    Chromatographic Purity and Enantiomeric Excess Limits

    Routine release testing applies reversed-phase high-performance liquid chromatography with UV detection at 220 nm or 254 nm. The area-percent method quantifies the main peak and related substances. Chiral purity is measured separately by chiral HPLC or by polarimetric comparison against an enantiomerically pure standard. The ranges below are commonly observed acceptance ranges, not a universal specification; individual supplier methods and applicable general chapters may differ.

    Quality parameterTypical acceptance rangeAnalytical basis
    AppearanceWhite to off-white crystalline powderVisual inspection
    HPLC purity≥ 98.0%RP-HPLC, USP <621>
    D-enantiomer≤ 0.5%Chiral HPLC
    Specific rotation [α]D20−31.0° to −34.0°, c = 1.0 g/100 mL, DMFPolarimetry, USP <781>
    Melting point114 °C to 116 °CDifferential scanning calorimetry or capillary
    Loss on drying≤ 0.5%USP <731>
    Residual solventsReported against ICH Q3C limitsHeadspace GC

    The melting point is not recommended as a release test for chiral purity because decomposition and polymorphic differences can shift the endotherm. When the derivative is intended for use in a peptide active pharmaceutical ingredient, laboratory controls are usually aligned with 21 CFR 211.160 and analytical method validation may follow ICH Q2(R2). Supplier documentation generally indicates no significant loss of HPLC purity after 24 months when stored at 2–8 °C in tight, light-resistant containers. Exposure to 0.1 M hydrochloric acid at room temperature leaves the Fmoc group largely intact for several hours, whereas primary or secondary bases remove it rapidly. Published formal stability data for this specific product under all storage configurations is limited; routine use should therefore rely on lot-specific certificates and controlled storage rather than extrapolated degradation kinetics.

    When Fmoc-L-proline Is Substituted for Boc-L-proline in Automated SPPS

    Substitution of Boc-L-proline by Fmoc-L-proline changes the deprotection chemistry from acidolysis with trifluoroacetic acid to base-mediated β-elimination with 20% piperidine in DMF. The Fmoc version enables the use of acid-cleavable resins such as Rink amide AM or Wang because final peptide cleavage with trifluoroacetic acid does not remove the Nα-protecting group. Boc strategy, by contrast, uses hydrogen fluoride or strong acid for final cleavage and is therefore constrained to specialized polytetrafluoroethylene apparatus and rigorous vacuum handling. In addition, Fmoc-L-proline absorbs strongly at 254 nm and, after deprotection, at 301 nm, allowing automated ultraviolet monitoring of deprotection efficiency; Boc-protected proline provides no equivalent chromophore.

    The secondary amine of proline is generally less prone to base-catalyzed racemization than oxazolone-forming linear amino acids. However, enolization of the activated carboxyl group can still occur if excess tertiary amine and prolonged activation are combined. Batch records from automated instruments using a HATU/DIPEA system generally specify a maximum preactivation temperature of 25 °C and a single-coupling reaction time of 30–60 min; double coupling is applied when the succeeding residue is sterically demanding. Published data for microwave-assisted synthesis with this specific derivative is limited, so conventional room-temperature protocols remain the default for validating critical coupling steps.

    Cbz-L-proline is removed by hydrogenolysis over palladium or by catalytic transfer hydrogenation. That route is incompatible with peptides containing sulfur-containing residues that poison the catalyst or with other reducible functional groups. Alloc-L-proline requires Pd(0) and a scavenger such as phenylsilane; residual palladium limits use in active pharmaceutical ingredient manufacture because trace-metal reporting under ICH Q3D becomes necessary. Fmoc-L-proline avoids transition-metal cleavage, and its deprotection by-product dibenzofulvene is sequestered as a piperidine adduct that can be rinsed from the resin with DMF. This distinction is material when the target peptide is intended for preclinical toxicology or for processes in which elemental impurity limits apply.

    Protected proline derivativePredominant removal conditionsCompatibility boundaryProcess-monitoring capability
    Fmoc-L-proline20% piperidine in DMF, 20–25 °C, 5–10 minStable to acid; removed by secondary aminesUV-active at 301 nm
    Boc-L-proline25–50% trifluoroacetic acid in dichloromethaneStable to base; removed by strong acidNo chromophore; Kaiser test required
    Cbz-L-prolineCatalytic hydrogenolysis or transfer hydrogenationStable to acid and base; incompatible with catalyst poisonsNo chromophore; thin-layer chromatography required
    Alloc-L-prolinePd(0) with phenylsilane or other allyl scavengersStable to acid and base; metal-sensitiveNo chromophore; residual metal testing required

    Dibenzofulvene Absorbance at 301 nm Quantifies Resin Loading

    Treatment with piperidine cleaves the Fmoc group by abstraction of the fluorenyl methine proton, forming a piperidine-dibenzofulvene adduct with an absorption maximum near 301 nm. This reaction is used to determine resin loading and coupling efficiency in Fmoc-L-proline-based sequences. A known volume of deprotection solution is collected, diluted in 20% piperidine/DMF, and measured in a quartz cell of 1 cm path length against a solvent blank. Molar absorptivity values for the adduct are commonly reported in the range 7,000–8,000 L mol−1 cm−1 at 301 nm; the exact value should be confirmed with a certified Fmoc-amino acid standard because solvent composition shifts the absorbance.

    Loading in millimoles per gram is calculated from the expression loading = (A301 × V × d)/(ε × l × m), where V is the volume of the deprotection solution, d is the dilution factor, ε is the molar absorptivity, l is the path length, and m is the resin mass. This quantitative method is compatible with Fmoc-L-proline-bound resins and allows in-process control at manufacturing scale without destructive sampling. The same dibenzofulvene release is used to verify complete Fmoc removal after each cycle; incomplete removal leaves a residual protected N-terminus and can reduce yield in the subsequent coupling.

    On automated synthesizers designed for 0.1 mmol to 10 mmol scale, Fmoc-L-proline is typically dissolved in DMF at 0.2–0.5 mol L−1 and delivered through solvent-resistant fluoropolymer tubing. Blockage of delivery lines has been observed when the solution is stored at 4 °C without agitation because the compound can crystallize at high concentration. Ambient temperature within 20–25 °C and continuous low-shear mixing reduce this risk. At production scale, batch-to-batch variation in residual DMF or dichloromethane affects the mass charged if the material is not corrected for loss on drying. Use of undried material in a 2-chlorotrityl chloride resin loading step can generate variable substitution, because residual water or protic solvent consumes resin-active sites. Pre-drying under vacuum at 25–40 °C until loss on drying is ≤ 0.5% is therefore applied when reproducible loading is required. Where factory relative humidity exceeds 60%, opened containers should be pre-dried or handled under nitrogen because moisture absorption may cause agglomeration, although published quantitative moisture-uptake data for this specific product is limited. The material should not be combined with primary or secondary amines, including piperidine, morpholine, or amino-functionalized resins, because these reagents initiate premature Fmoc removal. Contact with strong nucleophiles or alkaline aqueous solutions above pH 8 should also be avoided.

    Top